The LIVERFASt is an artificial intelligence-based algorithm that combines age, gender, weight and height with ten biomarkers (AST, ALT, GGT, total bilirubin, total cholesterol, triglycerides, fasting glucose, alpha2-macroglobulin, haptoglobin, and apolipoprotein A1) for the assessment of liver fibrosis, steatosis, and inflammatory activity. This evidence concerns the gene GPT and Hepatic fibrosis.